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Rattlesnake bite is a serious medical problem in the world today. 
In 1968, the Department of the Navy recorded 700 to 1000 bites due to 
rattlesnakes and 20 of those resulted in death (Vick, 1971). At the 
University of Texas Medical Branch clinic alone there were 214 patients 
treated for rattlesnake bite from 1952 to 1977 (Huang et al., 1977). 
Deaths due to rattlesnake bite are substantially lQwer in the United 
States than the rest of the world due primarily to the widespread use of 
commercially available antivenin (anti serum). A lth'ough the use of this 
antivenin is highly effective in preventing death it may not be effective 
against the extensive local tissue damage that results in severe disfigur-
ing or even loss of an extremity (Huang et al., 1977). This damage can 
occur even if the antivenin is injected immediately after the bite. Tech-
niques such as surgical debridement, cryotherapy, and the use of various 
chemicals, designed to neutralize the effects of the toxin, have not been 
entirely successful (Ownby, 1975; Ownby and Tu, 1977), therefore another 
treatment is needed to prevent local tissue damage. 
The venoms of most Crotalids produce hemorrhage and myonecrosis. 
Stringer et al. (1972) reported the Crotalus viridis viridis (Prairie 
rattlesnake) venom produces extensive hemorrhage and edema in muscle at 
the site of envenomation. When viewed with the light microscope, hemor-
rhage can be observed between fibers, and myonecrosis is found in focal 
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areas. Unaffected muscle fibers are interspersed among necrotic fibers. 
With the electron microscope, degeneration is first seen as dilation of 
the sarcoplasmic reticulum. Myeloid figures form in dilated sarcoplasmic 
reticulum, however, transverse tubules remain intact. Myofibrils break 
down, losing their striations and myofibrillar organization, until they 
become coagulated light and dark masses. Mitochondria appear to degener-
ate more slowly, not undergoing extreme degeneration until the fibrillar· 
structure is lost (Stringer et al., 1972). 
The isolation of a small, basic polypeptide from C. v. viridis venom 
by gel filtration and cation exchange chromatography has been reported 
(Ownby et al, 1976; Cameron and Tu, 1977). This polypeptide, named myo-
toxin ~{molecular weight of 4100 daltons, isoelectric pH of 9.6), was 
found to induce local myonecrosis, indistinguishable from that induced by 
the crude venom (Ownby et al, 1976). When muscle tissue was observed with 
the light microscope, 72 hrs post-injection, extensive vacuolation was 
evident in most fibers. Electron microscopic studies (Ownby et al, 1976) 
showed that dilation of the sarcoplasmic reticulum and perinuclear space 
was evident with the transverse tubules retaining a normal configuration. 
Many of the cisternae of the sarcoplasmic reticulum contained myeloid 
figures. At 72 hrs after injection sarcomeres of some fibers had lost 
their structural integrity. Those fibers that remained intact has sarco-
meres that were separated only by loosely arranged actin and myosin fila-
ments. Only the Z lines were evident, the A and I bands had disappeared. 
Neither hemorrhage nor edema was found in muscle injected with myotoxin ~· 
Since myotoxin ~-induced myonecrosis is essentially the same as that 
induced by crude ~· y_. viridis venom, and since commercial antivenin does 
not prevent this local damage, a method of treatment is needed that would 
prevent the myonecrosis induced by rattlesnake bites. This study was 
concerned with the production of antibody against purified myotoxin ~, 
subsequently called myotoxin, and the use of it in localization studies 
for the investigation of the binding site of the myotoxin. This infor-
mation is useful in the discovery of the mode of action of myotoxin on 
skeletal muscle cells. Other studies will concern the use of the anti-
serum in neutralization of myonecrosis induced by pure myotoxin, crude 
venom and other Crotalid venoms in order to prevent disfiguration of ex-
tremities in actual snakebite cases. 
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CHAPTER II 
MATERIALS AND METHODS 
Isolation and Homogeneity of Myotoxin 
Myotoxin was supplied by Dr. George V. Odel, Department of Biochem-
istry, Oklahoma State University. The isolation procedure, except for 
minor changes, was the same as described by Ownby et al. {1976) and later 
by Cameron and Tu (1977). Crude Prairie rattlesnake (f... y_. viridis) 
venom in lyophilized form, purchased from Miami Serpentarium Laboratories, 
Miami, Florida, was first fractionated by gel-filtration on a Sephadex G-
50 column (81 x 2 em). A sample of crude venom (250 mg) was dissolved in 
3 to 4 ml of a buffer composed of 0.05M tris (hydroxymethyl) aminomethane 
(Tris) buffer (pH 9.0 at 2l°C) and O.lM KCl. The column was developed 
with this buffer at a flow rate of 30 ml per hr and 5 ml fractions were 
collected. All procedures were done at 4°C. Eluate absorbance at 280 nm 
was monitored with a Perkin-Elmer model Coleman 101 spectrophotometer. 
Salt was removed from each of these fractions by dialysis using benzoy-
lated dialysis tubing (Sigma, St. Louis, Missouri) having an exclusion 
limit of 2000 daltons. 
After desalting and lyophilization the fractions were tested for my-
atoxic activity by intramuscular injection into white mice. Each fraction 
was dissolved in physiologic saline (0.85% NaCl), PSS, to give a final 
concentration of approximately 50 ~g per 0.1 ml. Seventy-two hours after 
injection of the solutions (0.1 ml per 20 gm mouse) into the lateral 
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dspect of the right thigh, the mice were killed by cervical dislocation, 
and a portion of muscle was removed from the medial aspect of the injected 
thigh. The muscle was fixed, processed and embedded in plastic (Epon 812) 
as previously described (Ownby et al., 1976). Thick (1 ~m) sections were 
cut, stained with t1allory•s Azure II Methylene Blue (Richardson et al., 
1960) and examined with the light microscope for damaged fibers. 
Fractions from the G-50 column which caused myonecrosis in mice were 
further fractionated by cation exchange chromatography on a C-25 (carbo-
xymethyl Sephadex) column (56 x 1.5 em). The C-25 column was equilibrated 
with the same buffer as used with the G-50 column. After developing the 
column with a stepwise KCl salt gradient (O.lM, 0.5M, 0.75M) in the 0.05M 
Tris buffer, 5 ml fractions were collected. Absorpance of the eluate was 
again monitored at 280 nm. Protein homogeneity was demonstrated by poly-
acrylamide disc' gel electrophoresis in the s-alanine system as previously 
reported (Reisfield et al., 1962; Ownby et al., 1976) using 15% gels, pH 
4.3, reversed electrodes. 
Production of Antiserum 
The immunogen was prepared by first dissolving 1.5 mg of the de-
salted, lyophilized myotoxin in 2 ml of physiologic saline. The final 
dose injected was 0.25 rng per kg for each of two rabbits. One male New 
Zealand white rabbit, and one male black satin rabbit, 4-5 months of age 
weighing about 3 kg, were first bled for pre-immune serum, and then each 
was injected with the immunizing antigen according to the following pro-
cedure. For the first injection, the myotoxin solution was emulsified 
with an equal volume of Freund•s complete adjuvant, and 2 ml of this 
emulsion was injected intramuscularly between the shoulder blades. One 
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week later a booster injection was given, which consisted of 2 ml of this 
emulsion of equal amounts of myotoxin solution and Freund's complete ad-
juvant. Bleedings were made at weekly intervals for three weeks then the 
procedure was repeated. Blood was collected by centrifugation and stored 
in sterile bottles at -20°C until used or used immediately. 
Separation and Purification of Antibodies 
Separation and purification of antibodies was by the procedure des-
cribed by Axelsen et al. (1973) with some minor changes. Antiserum from 
three bleedings of one rabbit was mixed with anrnonium sulfate (25 gm per 
100 ml of serum) and l~ft for 21 hrs at room temperature. Antibodies 
were precipitated by centrifugation at 4,000 x g for 15 min (I.E.C. re-
frigerated centrifuge). The supernate was discarded and the precipitate 
washed by resuspending with a solution of 25 gm (NH4)2so4 per 100 ml of 
distilled water and ceritrifuging at 4,000 x g for 15 min. The washing 
steps were repeated until the supernate was clean, at which time the pre-
cipitate was transferred to a dialysis bag by redissolving in a small 
amount of water. The antibody-containing precipitate was dialyzed at 4°C 
against distilled water for two changes of 12 hrs each; against 0.05M 
sodium acetate, 0.02H1 hydrogen acetate, pH 5.0, for 24 hrs; against dis-
tilled water for two changes of 12 hrs each; and against 0.025M acetate 
buffer, pH 4.9, for 24 hours. A precipitate of lipoproteins and immuno-
globulin M (IgM) formed during dialysis, was removed by centrifugation 
for 20 min at 20,000 x g in a Sorvall RC-2B refrigerated centrifuge. The 
supernate was saved, placed on an agarose column equilibrated with 0.025M 
acetate buffer and eluted with the same buffer. The eluate containing 
immunoglobulin G (IgG) and inununoglobulin A (IgA) was collected in 3 ml 
fractions and monitored at 280 nm for determination of the antibody con-
taining fractions. Pre-immune serum was treated in the same way for lgG 
separation. 
Detection of Antibodies 
The Ouchterlony agar-gel double diffusion technique (Clausen, 1969) 
was used to detect precipitating antibodies. Microdiffusion plates were 
prepared by pouring 7 ml of a 1.0% agarose solution in 0.85% NaCl into 
small Petri dishes. The agar was cut with a template to give one center 
well and six outer wells, 0.5 em between wells. Each well was filled 
twice with approximately 15 pl of solution, either antigen or antiserum. 
The wells were not allowed to dry between the two f~llings. Precipitin 
bands formed where antigens reacted with antibodies in the agar. Plates 
were incubated at room temperature in a moist chamber for 24 hrs after 
which no additional bands appeared. They were then photographed for a 
permanent record. 
Conjugation of Antibodies with Fluorescein 
Conjugation of globulins with fluorescein was by a procedure des-
cribed by Dr. Konrad C. Hsu, Professor of Microbiology, Department of 
Microbiology, College of Physicians and Surgeons, Columbia University 
(Andres et al., 1973). 
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First, the protein concentration of antimyotoxin ~ IgG and preimmune 
IgG was determined by the Lowry method (Lowry et al, 1951). A solution 
was made to contain 20 mg of globulin per ml in a mixture containing 1 ml 
of 0.5M carbonate-bicarbonate buffer (pH 9.5) and 4 ml of physiological 
saline (0.85% NaCl). Fluorescein isothiocyanate (FITC) power (0.05 mg 
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per ml of protein in the reaction mixture) was added, and the mixture was 
stirred with a magnetic stirrer overnight at 4°C. This was followed by 
dialysis against phosphate buffered saline, PBS (0.05M sodium phosphate, 
0.85% NaCl, pH 7.4) for 5-7 days, changing PBS twice daily, until the 
dialyzing fluid showed no fluorescence in ultraviolet light. Following 
dialysis, the conjugated globulin was passed through a Millipore filter 
to insure sterility, and stored at 4°C. The absorbance was determined at 
495 nm (E495 ) and 280 nm (E280 ) for calculation of the molecular fluores-
cein/protein ratio (mol. F/P). The mol. F/P was calculated according to 
the equation given by The et al. (1970) who assumed a molecular weight of 
160,000 for IgG and of 390 for FITC in its derivation. 
Mol. F/P 
Localization of t~yotoxin 
_l_njection fro~edures_ 
A mouse was injected with 0.1 ml of myotoxin {5.0 ~g/gm mouse weight) 
into the medial aspect of the right thigh. Another mouse was injected 
with an equivalent volume of physiologic saline (PSS). Two hours post-
injection the mice were killed by cervical dislocation, and the medial 
portion of the right thigh was exised. The muscle was either fixed in 1% 
paraformaldehyde and washed overnight in PBS (0.1 M sodium phosphate) or 
placed directly into 0.7M phosphate buffer. It was then rinsed in 0.7M 
phosphate buffer (pH 7.4) which included 5% sucrose as a cryoprotectant 
and frozen in liquid nitrogen. Cryostat sections (4 Jlm) were placed on 
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coverslips coated with 11. gelatin then air dried and stored at -25°C in 
the cryostat until used. Serial sections were taken so adjacent sections 
could be used in localization studies. This made possible direct compar-
ison of specific muscle cells between experimental and controls. Some 
sections of muscle injected with PSS were subsequently incubated in myo-
toxin (0.1 mg/ml) then washed four times at 15 min each with PBS (0.01 M 
sodium phosphate). These sections composed the tissue for the in vitro 
treatment with myotoxin. 
Sections used in this procedure consisted of: 1) myotoxin-injected 
muscle {in vivo), 2) PSS-injected muscle (control), and 3) PSS-injected 
I . 
muscle incubated in myotoxin (in vitro). Antibody preparations were all 
absorbed with homogenized muscle for 12 hrs to reduce nonspecific fluor-
escence and then diluted 1:20 with PBS prior to use. Sections were all 
incubated one hour in either preimmune IgG conjugated with FITC absorbed 
with muscle; antimyotoxin IgG conjugated with FITC absorbed with muscle; 
anitmyotoxi n IgG conjugated with FITC absorbed with muscle and myotoxi n •. 
After this incubation sections were washed four times for 15 min each with 
PBS and coverslipped using 90% glycerol. Sections were viewed·with a 
Zeiss fluorescent photomicroscope and recorded on Kodak Tri-X Pan film. 
Indi r~~J Fluorescein La be li!!g_ 
Cryostat sections were obtained as described for the direct labeling 
technique and washed four times at 15 min.each with PBS. They were then 
incubated in a moist chamber for one hour at room temperature in one of 
the following: preimmune IgG, antimyotoxin IgG (10 mg/ml) both absorbed 
10 
with muscle or Mltimyotoxin IgG absorbed with muscle and myotoxin. All 
sera were di"luted 1:10 wHh PBS (0.01 M sodium phosphate) prior to use. 
Follo\'ling incubation sections were washed four times at 15 min each with 
PBS and incubated one hour at room temperature in a 1:20 dilution of goat 
anti-rabbit IgG fluorescein conjugated (Grand Island Biological Company, 
Grand Island~ New York). Sections were washed four times at 15 min each 
with PBS (0.01 M sodium phosphate), coverslipped using 90% glycerol, 
viewed and recorded as described above. 
Jpdire~~ Ferrj~i~ Labeling for Electron Microscopy 
Mice were injected and tissue was excised as previously described. 
Tissue was either placed inmediately into 0.7M phosphate buffer plus 5% 
sucrose (pH 7.4) and frozen in liquid nitrogen, or the tissue was ~irst 
fixed for one hour in 1% paraformaldehyde then washed overnight in PBS, 
(0.1 M sodium phosphate), rinsed in 0.7M phosphate buffer plus 5% sucrose 
and frozen in liquid nitrogen. Cryostat sections (21 ~m) on coverslips 
were air-dried and stored until use at -25°C. Agarose (2% at 40-45°C) 
was poured over the sections which were mounted on coverslips, and cooled. 
The agarose was cut into blocks containing the tissue on one surface~ and 
placed into vials containing PBS (0.01 M sodium phosphate). Some blocks 
containing PSS-injected sections, were incubated in 0.1 mg/ml myotoxin 
for one hour and washed four times at 15 min each in PBS (0.01 M sodium 
phosphate). Blocks containing PSS-injected muscle incubated in myotoxin 
were incubated one hour in antimyotoxin lgG (10 mg/ml) absorbed with 
muscle or preirrtnune lgG absorbed with muscle both diluted 1:10 with PBS 
(0.1 M sodium phosphate). Following this incubation blocks .were washed 
four tin~s at 15 min each with 0.05M phosphate buffer, pH 7.2, then 
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incubated one hour in sheep anti-rabbit IgG, ferritin conjugated, (Cappel 
Laboratories, Downington, Pennsylvania) diluted 1:20 with 0.05M phosphate 
buffer, pH 7.2. Following incubation blocks were washed four times at 15 
min each with 0.05 M phosphate buffer, pH 7 .2, then rinsed with cacody-
late buffered wash (O.lM sodium cacodylate and 6% sucrose at pH 7.4). 
The tissue was fixed one hour in 2% glutaraldehyde, washed four times at 
15 min each with cacodylate buffered wash, postfixed one hour in 1% os-
mium tetroxide, dehydrated in a graded acetone series, and embedded in 
Epon 812 in flat molds. The muscle blocks were sectioned with an LKB 
ultratome I and viewed unstained with a Philips EM 200 electron micro-
scope. Some sections were double stained with uranyl acetate and lead 
citrate for electron microscopic examination to compare morphology of 
i 
fixed versus unfixed tissue. 
CHAPTER I II 
RESULTS 
Isolation of Myotoxin 
Four fractions were obtained from fractionation of crude venom on 
the Sephadex G-50 column, as is shown by the elution profile in Figure 1. 
Each fraction was tested for myotoxic activity by injection into mice; 
only fractions 2 and 3 caused myonecrosis. Further fractionation of frac-
tions 2 and 3 by cation exchange chromatography on a CM Sephadex (C-25) 
column resulted in the elution profile shown in Figure 2. Out of five 
fractions obtained only fractions 1 and 3 caused muscle necrosis in mice. 
Fraction 3 corresponded to myotoxin ~(Ownby et al., 1976; Cameron and 
Tu, 1977) and was used in all these experiments. Protein homogeneity was 
demonstrated by ployacrylamide disc gel electrophoresis in the a-alanine 
system and the purified C-25 fraction 3 is shown in Figure 3. A portion 
of this fraction was assayed and an example of the myonecrosis induced is 
shown in Figure 4. 
Antiserum to Myotoxin 
When antiserum from the first bleeding was tested in gel-diffusion 
plates against dilutions of myotoxin (0.4 mg/ml and diluted 1:2, 1:4, 
1:8, 1:16 down to 1:512) or as shown in Figure 5a when myotoxin IgG [110 
mg/ml (Lowry et al., 1951) and diluted 1:2, 1:4, 1:8, and 1:16], one pre-




Elution Profile for Sephadex G-50 Gel-Filtration Column. 
Crude C. v. Viridis venom (250 mg} was dissolved in elution 
buffer-consisting of 0.05M Tris and O.lM KCl (pH 9.0 at 
2l°C). Elution with the same buffer results in four frac-
tions. Fractions 2 and 3 were found to cause myonecrosis 
and were placed on the cation exchange column. 
Elution Profile for CM Sephadex (C-25) Cation Exchange Column. 
Fractions 2 and 3 were dissolved in elution buffer consist~ 
ing of 0.05M Tris and O.lM KCl (pH 9.0 at 2l°C). After· 
equilibration with this buffer, the column was eluted with 
a stepwise KCl gradient (O.lM, 0.5M, 0.75M) in 0.05M Tris 
buffer. Fractions l and caused myonecrosis. Only fraction 
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Figure 3. B-Alanine Disc Gel Electrophoresis. Electrophoretic homogene-
ity of myotoxin a is demonstrated by the presence of only 
one band in the e-lectrophoresis gel. Approximately 100 J.Jg 
of myotoxin a (fraction 3 from the CMS-25 column, Figure 2) 
was applied to 15% acrylamide gels which were run at pH 4.3 
with electrodes reversed. Gels were stained with 0.05% 
Coomassie blue and 10% trichloroacetic acid, destained with 
20% Cl 3AcOH and stored in 7.5% acetic acid. Anode is on 
left. Top of gel is at single arrow. Myotoxin a is be-
tween double arrows. -
Figure 4. Photomicrograph of Mouse Skeletal Muscle Injected With Myo-
toxin a. Mice were injected intramuscularly with 2.0 vg/ 
gm of myotoxin a (fraction 3 from CMS-25 column, Figure 2} 
dissolved in physiologic saline. Muscle was taken 24 hrs 
after the injection and routinely processed for plastic 
embedding. Thick (1 J.Jm} sections were taken and stained 
with Mallory•s Azure II Methylene Blue. Note extensive 
vacuolation of muscle cells which indicates damage to cell 
(V). Also, note adjacent normal appearing muscle cells 
(M). No vacuolation was observed in control muscle in-
jected with physiologic saline and processed along with 
the experimental tissue. 
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Figure 5. Ouchterlony Agar Gel-Diffusion Plates (1% Agarose in PSS) 
a. Center well: myotoxin ~' 0.1 mg/ml. Peripheral wells: 
(1) antimyotoxin a IgG, 110 mg/ml; (2) antimyotoxin a 
IgG dilutedl:2; \3) antimyotoxin a IgG diluted 1:4;-
(4) antimyotoxin a IgG diluted 1:8; (5) antimyotoxin a 
IgG diluted 1:16;-(6) preimmune IgG. -
b. Center well: antimyotoxin a IgG. Peripheral wells: 
(1) myotoxin a, 0.1 mg/ml; \2) and (6 1) crude C. v. 
viridis venom-; 1 mg/ml; (3), (4), and (5) empty.-
c. Center well: crude C. v. viridis venom, 1 mg/ml. 
Peripheral wells: (T) Wyeth's Polyvalent Crotalidae 
antivenin; (2) and (6) antimyotoxin ~ IgG; (3), (4), 
and (5) empty. 
d. Center well: myotoxin a, 0.1 mg/ml. Peripheral wells: 
(l) antimyotoxin a IgG;-(2) antimyotoxin a IgG absorbed 




One pn~cipitin line formed between myotoxin a_ (fraction 3) from two dif-
f(~renl isolations, but no line formed against pre-inunune serum. Both 
rabbits gave essentially the same results, except that one produced anti-
serum of a slightly higher titer. Neither pre-immune serum ever produced 
a precipitin line against myotoxin or crude venom. When anitmyotoxin IgG 
was run against myotoxin and crude~- ~· viridis venom, precipitin lines 
formed which showed total identity (Figure 5b). No precipitin lines were 
formed between myotoxin and Wyeth's polyvalent Crotalidae antivenin, how-
ever, one line formed between crude C. v. viridis venom and antivenin. 
Figure 5c shows the lack of identity between the immunoprecipitin line 
between antimyotoxin serum and crude venom and the line between commercial 
antivenin and crude C. v. viridis venom. Figure 5d shows lack of a pre-
cipitin line between myotoxin and preimmune IgG, presence of a line be-
tween myotoxin and antimyotoxin IgG, and absence of line between myotoxin 
and antimyotoxin absorbed with myotoxin indicating the specificity of the 
antibodies for myotoxin. The precipitin line between antimyotoxin IgG 
and antimyotoxin IgG absorbed with myotoxin is probably due to excess myo-
toxin not bound for IgG in the absorbed antiserum. 
Localization by Immunofluorescence 
Tissue that had been fixed in 1% paraformaldehyde showed much non-
specific binding of fluorescein in all controls. Some muscle fibers were 
brightly fluorescent, while other fibers were relatively low in fluores-
cence. However, morphology was good in fixed tissue. Muscle cells in 
longitudinal section showed distinct striations with the sarcolemma 
appearing to remain intact. In unfixed tissue non-specific fluorescein 
binding was greatly reduced, but morphology was not as good as in fixed 
tissue. Muscle striations were less apparent, although the sarcolemma 
appeared to remain intact. 
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Sections of muscle incubated in myotoxin (in vitro) and reacted with 
anti-myotoxin IgG conjugated with FITC (mol. F/P ratio of 1.8) showed 
strong fluorescence along the sarcolenma of muscle cells as shown in Fig-
ures 6a and 7a. Controls showed decreased fluorescence along the sarco-
lemma (Figures 6b-c and 7b-c). Non-specific fluorescence using the direct 
immunofluorescent technique was minimal. Sections of muscle taken from 
mice injected with myotoxin (in vivo) showed very little fluorescence 
(Figure 8). Localization, by indirect immunofluorescence, showed much 
nonspecific binding of fluorescein in both fixed and unfixed tissue. Due 
to this intense background staining, it was impossible to determine local-
ization of myotoxin. 
Localization by Immunoferritin 
Poor 111orphology was noted in localization of myotoxin by indirect 
ferritin labeling, tissue that was immediately frozen and not fixed. The 
sarcolenuna was discontinuous, detached, and laminated. There were mem-
brane whorls present indicating a degeneration of cellular organelles. 
Also, the sarcoplasmic reticulum was swollen (Figure 9a). 
In fixed tissue, morphology was quite good. The sarcolemma appeared 
intact, and mitochondria were normal with intact cristae. The sarcoplas-
mic reticulum retained a normal appearance in PSS-injected muscle and a 
swollen appearance in mytoxin-injected muscle. Transverse tubules were 
intact and myofibrils appeared nonnal with striations prominent. Ferri-
tin was located along the sarcolemma of both experimental (Figure lOa) 
but also of control (Figure lOb) tissue, indicating a high degree of 
Figure 6. In Vitro Localization by Itmnunofluorescence: 
---Sections of ~1uscle 
Cross 
a. Muscle cells (M) incubated with myotoxin a, 0.1 
mg/ml, and in antimyotoxin a IgG conjugated 
\'lith fluorescein and absorbed with muscle. Myo-
toxin is evidenced by bright fluorescence along 
the sarcolemma (S) and within the muscle cells 
(M). 
b. Muscle cells (M) incubated in myotoxin a, 0.1 
mg/ml, and in antimyotoxin a IgG conjugated 
with fluorescein, absorbed with myotoxin a as a 
negative control and absorbed with muscle~ Note 
the decreased fluorescence of the sarcolemma (S) 
and of muscle cells (M), as compared with Figure 
6a. 
c. Muscle cells (t1) incubated in myotoxin a, 0.1 
mg/ml, and in preimmune IgG conjugated with 
fluorescein and absorbed with muscle. Note the 
decreased fluorescence of the sarcolemma (S) and 
of muscle cells (M), as compared with Figure 6a. 
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Figure 7. In Vitro Localization by Immunofluorescence: 
--Sections of Muscle 
Longitudinal 
a. Muscle cells (M) incubated in myotoxin a, 0.1 mg/ml, 
and in antimyotoxin a IgG conjugated with fluorescein 
and absorbed with muscle. Myotoxin is evidenced by 
bright fluorescence alony the sarcolemma (S) and 
muscle cells (M). 
b. Muscle cells (M) incubated in myotox~n .!• 0.1 mg/ml, 
and in antimyotoxin a IgG conjugated with fluores-
cein, absorbed with inyotoxin ~as a negative control 
and absorbed with muscle. Note the decreased fluo-
rescence of sarco 1 emma ( S) and of muse 1 e ce 11 s (M), 
as compared with Figure 7a. 
c. Muscle cells (M) incubated in myotoxin a, 0.1 mg/ml, 
and in preimmune IgG conjugated with fluorescein and 
absorbed with muscle. Note the decreased fluores-
cence of sarcolemma (S) and muscle cells (M), as 
compared with Figure 7a. 
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Figure 8. In Vivo Localization by Immunofluorescence: 
---Sections of Muscle 
Cross 
a. Muscle cells (M) of mouse muscle injected with 
myotoxin and incubated in antimyotoxin a IgG 
conjugated with fluorescein and absorbed with 
muscle. No fluorescence is evident along the 
sarcolemma (S) or within muscle cells (M). 
b. Muscle cells (M) of mouse muscle inJected with 
myotoxin a and incubated in antimyotoxin a IgG 
conjugated- with fl uores cei n, absorbed with myo-
toxin a, and absorbed with muscle. Note ab-
sence of fluorescence along the sarcolemma (S) 
and within muscle cells (M). 
c. l~uscle cells (M) of mouse muscle injected with 
myotoxin ~and incubated in preimmune IgG con-
jugated with fluorescein and absorbed with 
muscle. Note absence of fluorescence along 
the sarcolemma (S) and within muscle cells (M). 
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Figure 9. Electron Micrographs rif Unfixed and Fixed Mouse Skeletal 
Muscle 
a. Section of unfixed muscle processed for electron 
microscopy and double stained with uranyl acetate 
and lead citrate. Note the ruptured, sarcolemma 
(S) and the presence of membrane whorls (W). The 
sarcoplasmic reticulum (SR) is swollen. Connec-
tive tissue (CT). ~1yofibrils (Mf). 
b. Section of muscle fixed in 1% paraformaldehyde, 
processed for electron microscopy and double 
stained with uranyl acetate and lead citrate. 
Muscle showing a more normal appearance of mito-
chondria (Mi), sarcoplasmic reticulum (SR), sar-
co 1 errrna ( S) , and myofi bri 1 s (t1f) . There was some 
damage from ice crystal formation (I) during pro-
cessing. Connective tissue (CT). 
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Figure 10. Electron r1icrographs of lB_ Vivo Immunoferritin 
Loca 1 i zati on ·· 
a. Longitudinal section of part of a muscle 
cell of mouse muscle injected with myo-
toxin and incubated first with rabbit anti-
myotoxin a IgG and second with goat anti-
rabbit lg~ conjugated with ferritin. Note 
presence of ferritin (F) localized along 
the sarcolemma. Also, note dilatated sar-
coplasmic reticulum (SR) and myofibril 
(~1f) . 
b. Longitudinal section of part of a muscle 
cell of mouse muscle injected with myo-
toxin and incubated first with rabbit pre-
immune lgG and second with goat anti-
rabbit lgG conjugated with ferritin. Note 
the increased amount of ferritin (F) along 
the sarcolemma, as compared with Figure 
lOa, indicating nonspecific binding. Also, 
note dilatated sarcoplasmic reticulum (SR) 
and myofibril (Mf). 
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nonspecific binding and making localization of myotoxin impossible. The 
amount of ferritin on the sarcolemma varied from cell to cell (Figures lOa 
and lOb) within a given section of experimental or control muscle. 
CHAPTER IV 
DISCUSSION 
The frattionation of C. v~ viridis venom resulted in the isolation 
of two myotoxic components. Fraction 3 from the carboxymethyl Sephadex 
column produced myonecrosis in mice identical to that reported by Ownby 
et al. (1976) and by Cameron and Tu {1977) as induced by myotoxin _!. 
Only myotoxin ~was used in this study and is subsequently referred to 
as myotoxin. 
The injection of myotoxin into rabbits elicited the fonnation of 
specific antibodies. The formation of one precipitin line between myo-
toxin and antiserum indicated that at least one antibody exists to the 
myotoxin, and since there was never any precipitin lines formed between 
preimmune serum and myotoxin, the possibility of the precipitin line be-
ing due to non-immune sources was very remote. Also the line between 
myotoxin and antimyotoxin serum reacted with complete identity with the 
1 i ne between crude ~-· y __ . vi ri dis_ venom and antimyotoxi n, confi nni ng the 
presence of the purified myotoxin in its homologous crude venom. 
The gel-diffusion results indicated no reaction between corrmercial 
antivenin and myotoxin. There were no precipitin lines that formed be-
tween crude C. v. viridis venom and corrmercial antivenin that identified 
with the precipitin line that formed between antimyotoxin serum and~· v. 
viridis venom (Figure 5d). The absence of antibodies in antivenin to 
myotoxin components could explain its relative ineffectiveness in 
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preventing myonecrosis induced by rattlesnake (Crotalidae) envenomation. 
At least two factors could account for the poor immunogenicity of myo~ 
toxic components: (1) their small molecular weight (myotoxin _!, 4100}, 
and (2) their low concentration, due to dilution, resulting from mixing 
four crude venoms in the preparation of the immunizing antigen for pro-
duction of antivenin. 
In localization of myotoxin, utilizing fluorescein, it was necessary 
to use a variety of controls in order to demonstrate the fluoresce-nce due 
only to myotoxin. Controls that were used for direct localization stud-
ies included: (1) sections of PSS-injected muscle incubated in myotoxin, 
followed by incubation by either (a) antimyotoxin lgG conjugated with' 
FITC absorbed with myotoxin, (b) preinrnune lgG conjugated with FITC; (2) 
sections of PSS-injected muscle not incubated in myotoxin incubated in 
either (a} antimyotoxin IGG conjugated with FITC, (b) antimyotoxin IgG 
conjugated with FITC absorbed with myotoxin, or (c) preimmune IgG conju-
gated with FITC. Results from the in vitro myotoxin treatment of adja-
cent sections followed by incubation with antimyotoxin conjugated with 
FITC showed bright fluorescing of the sarcolemma and structures within 
the cell (Figures 6a and 7a). The adjacent section treated with anti-
. myotoxin that had been absorbed with myotoxin showed removal of nearly 
all the fluorescence along the sarcolemma and within the muscle cell 
(Figures 6b and 7b}. The amount of fluorescence removed by absorbing 
out the antimyotoxin lgG represents the myotoxin that was bound to the 
muscle cells. By using adjacent sections identical muscle fibers can be 
compared, decreasing interpretation errors due to nonspecific fluorescein 
binding. Problems with resolution and nonspecific binding of fluorescein-
labeled antibodies preclude more precise localization. Nonspecific 
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fluorescence of the muscl(~ in the direct labeling techniques could be due 
to either nonspecific binding of the Fe portion of the IgG molecule or to 
molecular fluorescein/protein (mol. F/P) ratios being too high. To eli-
minate binding of the Fe portion of IgG, pepsin digestion could be used 
to separate the Fab2 fragments (Wylie et al., 1979). It was detennined 
by The and Feltkamp (1970) that nonspecific fluorescence was present in 
all cases in which the mol. F/P ratio was higher than 5, and nonspecific 
fluorescence was not present, if the mol. F/P ratio was below 3. 'Since 
the FITC conjugate used in this study had a mol. F/P ratio of 1.8, this 
was probably not the source of nonspecific fluorescence. However, the 
mol. F/P ratio obtained for the fluorescein conjugated antibody was an 
average value, and the IgG solution would contain a percentage of mol. 
I 
F/P ratios above and below this value. In order to be sure that no mol. 
F/P ratios above 5 were present in the antibody conjugate, it could be 
fractionated on a gel-filtration column, and mol. F/P ratios calculated 
for each fraction. The mol. F/P ratios, that were above 5, could then 
be discarded. 
These problems could explain the failure of the indirect labeling 
technique to produce consistent and valid results. To avoid these prob-
lems, the first antibody (antimyotoxin IgG) could be separated into only 
Fab2 fragments of IgG, thereby reducing nonspecific Fe fragment binding. 
The second antibody could be Fab2 fragments conjugated with FITC made 
against Fab2 fragments of rabbit IgG. In the indirect fluorescein label-
ing, the mol. F/P ratio of the second antibody could have been checked. 
ll! yitro localization of myotoxin showed definite binding to the 
sarcolellilla and inside muscle cells, but this was in an in vitro situation 
and may not represent what actually occurs in an in vivo situation. 
However, the muscle damage produced by myotoxin in vitro is similar to 
that induced by in. vivo treatment with myotoxin, at least at the time 
interval studied. Results obtained from in vivo direct localization ---
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studies were difficult to interpret due to poor fluorescence which was 
probably due to a low concentration of myotoxin within the muscle. Low 
amounts of myotoxin could result from there being only limited amounts 
of myotoxin available for binding to muscle cells or to myotoxin being 
rapidly metabolized by muscle cells. 
Incubation of muscle in myotoxin resulted in localization of the 
toxin along the sarcolemma as well as inside the cells. This means that 
myotoxin could be binding to both sarcolemma and sarcoplasmic reticulum, 
and to other cellular organelles including myofilaments. Thus localiza-
. i 
tion at this level (light microscopy) does not allow us to pinpoint the 
actual site of myotoxin. 
The primary action of myotoxin as proposed by Ownby et al. (1976) 
is dilatation of the sarcoplasmic reticulum, which could result from sev-
eral types of initial action. This could result from inhibition of ion 
transport at the level of the sarcolemma. Sodium-potassium adenosine 
triphosphatase (Na+-K+ ATPase), an enzyme necessary for the active trans-
port of Na+ out of the cell and K+ into the cell, is inhibited by oua-
bain, a cardiac glycoside. In skeletal muscle treated with ouabain the 
initial effect is dilatation of the sarcoplasmic reticulum (Ginn et al., 
1968; Knight, 1978). This dilatation of sarcoplasmic reticulum is the 
same initial effect observed when skeletal muscle was treated with myo-
toxin (Ownby et al.. 1976; Knight, 1978). The Na+- K+ pump is closely 
associated with the plasma membrane of cells and any alteration in the 
cell membrane, such as blocking the Na+ -K+ pump with ouabain, would 
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result in a change in its permeability characteristics. It was suggested 
by Ginn et al. (1968) that blocking the pump resulted in the influx of 
sodium, chloride, and water, and the efflux of potassium. The water 
accululated in the endoplasmic reticulum causing enlargement, and even-
tual expansion of all cellular compartments, and distortion of cell mem-
branes. However, it was shown by Knight (1978) that myotoxin does not 
demonstrate the same physiological responses as ouabain. Knight proposed 
that myotoxin did not affect the Na+- K+ ATPase system, but instead might 
affect the calcium transport mechanism. This would have the same ultra-
structural changes as ouabain but could explain the physiologic response 
of initial spasms and decline in contractile response reported by Knight 
(1978). t·1yotoxin a could be altering the sarcolel111la, causing it to be-
. . - i 
come more permeable to calcium ions and, subsequently, to water. Calcium 
in the sarcoplasm could then trigger contraction and also additional Ca++ 
release from the sarcoplasmic reticulum (Endo, 1977; Crevey et al., 1978) 
which could eventually lead to myofilament degradation (Duncan and Smith, 
1978) as observed by Ownby et al. (1976) using myotoxin .!· · 
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